Fig. 3From: IGF2 reduces meiotic defects in oocytes from obese mice and improves embryonic developmental competencyIGF2 administration improves the embryonic developmental competency of oocytes from obese mice (A) Schematic diagram indicating treatment plan of embryos in culture medium in vitro. B Quantitative analysis of morula and blastocyst in ND (n = 72), HFD (n = 57), and HFD+ IGF2 (n = 49). C Morphology of embryos cultured in vitro and examined at the blastocyst developmental stage. The arrows point to embryos that developed into blastocysts; the arrowheads showing the embryos which failed to transform into blastocysts. Scale bar, 300 μm. D Quantification of the total and TE number of cells in ND (n = 37), HFD (n = 20) and HFD + IGF2 (n = 26) blastocysts. E Representative images of blastocysts of the ND, HFD, and HFD + IGF2 groups. The trophectoderm (TE) was stained with CDX2 (green), and chromosomes were counterstained with DAPI (blue). Scale bar, 20 μm. NS, not significant. *p < 0.05. One-way ANOVA test was used for statistical analysis. Error bars indicate the SEMBack to article page